PUBLISHED DATE : Sep 2017 | Pages : 169
Fill out your details & get your free sample
Intraoperative Neuromonitoring (IONM) Market Size, Share, Trends, Analysis Report by Source Types (In-sourced and Outsourced), Methodology Types (Evoked Potential (EP), Electromyography (EMG), and Electroencephalography (EEG)), Application Types (Neurosurgery, Orthopedic surgery, ENT surgery, and Cardiovascular surgery) and Geography (APAC, Europe, North America, Latin America, and Middle East & Africa) Industry Analysis Report, Regional Outlook, Growth Trends, Competitive Landscape, Share & Forecast, 2017–2022
169 Pages
30 Tables
91 Charts
5 Regions
11 Countries
17 Companies
4 Market Segment
| Report Attribute | Details |
|---|---|
| Market Size (Revenue) | USD 4 BILLION (2022) |
| CAGR | 8% (2016-2022) |
| Base Year | 2016 |
| Forecast Year | 2022 |
| Market Segments | By Source Types (In-sourced and Outsourced), Methodology Types (Evoked Potential (EP), Electromyography (EMG), and Electroencephalography (EEG)), Application Types (Neurosurgery, Orthopedic surgery, ENT surgery, and Cardiovascular surgery) |
| Geographic Analysis | APAC, Europe, North America, Latin America, and Middle East & Africa |
| Countries Covered | US, Canada, Japan, Australia, China, India, UK, France, Germany, Brazil, and Mexico |
Intraoperative neuromonitoring (IONM) encompasses the application of a wide variety of electrophysiological methods to monitor the functional integrity of the nervous system during surgical interventions.
High burden of healthcare expenditures, patients and healthcare providers’ preferences for choice of treatment with negligible/no risk post-surgical complications options have fuelled the demand for Intraoperative neuromonitoring services globally. The number of establishments providing outsourced IONM has also increased considerably in recent years in the US. Thus, opportunities witnessed by the Intraoperative neuromonitoring (IONM) market in US are highly lucrative.
The report provides a holistic view of the market, the companies involved, and the factors driving its growth. It also provides information on some of the latest trends that have started to surface and are likely to become strong market driving forces over the next five years. This report also provides the Porter’s Five Forces analysis along with a description of each force and its impact. Further, the report also provides complete value chain analysis of the global market.
Vendors majorly focus on merger & acquisition to strengthen their presence
The global market can be termed as attractive one because of the growth prospects it holds. Mergers and acquisition are the major strategies used by vendors to generate larger shares. The report includes the news and details of the key mergers and acquisition of major vendors in the industry. Major vendors include SpecialtyCare, Natus, NuVasive, Medtronic, inomed Medizintechnik GmbH.
Other emerging vendors are Accurate Monitoring, Cadwell Industries, Computational Diagnostics, Bromedicon Neuromonitoring, Clinical Neurodiagnostics, CNS Neuromonitoring, Dr. Langer Medical GmbH, IntraNerve, Medsurant Health, Neuro Alert, Neurophysiology Services Asia, and Nihon Kohden Corp.
Advent of portable and multi-modality IONM devices to boost the revenues
Increase in volume of surgical procedures, growing utility of intraoperative neuromonitoring in varied surgeries, technological innovations and increase in use of out-sourced Intraoperative neuromonitoring by small and rural healthcare centers are the major factors that are enhancing the growth. Increasing demand for tele-neuromonitoring, advent of portable and multi-modality IONM devices, increase in strategic consolidations and integration of MI surgeries with intraoperative neuromonitoring are the latest trends that will boost the market and will pave the way for growth opportunities.
Neurosurgery segment is likely to be the dominant segment during the forecast period
Outsourced segment is growing at a rapid pace due to its benefits over in-sourced monitoring. Hospitals prefer outsourced monitoring as it eliminates the need for purchase of premium priced Intraoperative neuromonitoring capital equipment and avoid the requirement to appoint full-time IONM professionals.
In terms of modality, the EP segment dominated with around 68% in the global Intraoperative neuromonitoring (IONM) market shares due to its broad range of surgical applications and the high utilization rate. This segment is anticipated to be driven at a slightly growth rate during 2016−2022 and will retain to be major segment during the forecast period. In terms of the growth rate, orthopedic surgeries are likely to grow at a higher CAGR than other surgical types. However, neurosurgery will remain the major revenue contributor during the forecast period in the application segment.
The North America market is likely to be the largest during the forecast period
The primary factor for the high share of North America is the existence of the favorable and constantly improving reimbursement scenario in the region. The penetration of Intraoperative neuromonitoring devices is significantly higher in the US than other developed or developing countries worldwide. Their demand in this region is also rapidly growing increased in rate of utilization of IONM for varied surgeries and due to increase in demand for out-sourced services. Europe is the second largest region, followed by APAC, Latin America, and MEA.
The Intraoperative Neuromonitoring (IONM) market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:
By Source Types
By Methodology Types
By Application Types
By Geography
Frequently Asked Questions
The Intraoperative Neuromonitoring (IONM) market size to reach revenues of around $4 billion, growing at a CAGR of 8% during 2016-2022.
Which source/application/region is generating the largest revenue in the Asia Pacific region?
APAC accounted for the third largest share of the global IONM market in 2016. Japan is the most prominent market for IONM in this region.
The IONM market in Europe is projected to grow at a moderate pace during the forecast period due to increase in utilization of IONM for varied surgeries.
Outsourced segment is growing at a rapid pace due to its benefits over in-sourced monitoring.
The players in the market include SpecialtyCare, Natus, NuVasive, Medtronic, and inomed Medizintechnik GmbH.
SpecialtyCare, Natus, NuVasive, Medtronic, and inomed Medizintechnik GmbH are the leading players in the global intraoperative neuromonitoring (IONM) market. The global IONM market is expected to cross $4 billion, growing at a CAGR close to 7.8% during 2016–2022. The market for IONM is relatively entrenched in developed countries, especially in the US and Europe. North America will lead the market and the US will have the maximum share (90%) of the total market share in the region. The orthopedic surgery segment is likely to post the highest growth CAGR in the application segment, whereas the neurosurgery segment will remain the largest market. The EP segment will dominate the market during the forecast period.
Global IONM Market Segmentation
Report Timeline
Major vendors profiled in the report are as following:
Other emerging vendors are Accurate Monitoring, Cadwell Industries, Computational Diagnostics, Bromedicon Neuromonitoring, Clinical Neurodiagnostics, CNS Neuromonitoring, Dr. Langer Medical GmbH, IntraNerve, Medsurant Health, Neuro Alert, Neurophysiology Services Asia, Nihon Kohden Corporation.
Scope of the Report
The study considers the present scenario of the global IONM Market and its market dynamics for the period 2016−2022. It covers a detailed overview of various market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. The report also profiles and analyzes the leading five companies and 15 other prominent companies operating in the market.
The sale of major IONM market companies was aggregated to arrive at the market size. The same approach is used to calculate the market size in terms of revenue. An estimated 85−90% of vendors’ capacity are mapped and considered in the calculations.
The report provides the analysis of the key segments of the market by end-users, geography, and vendors. It provides a detailed analysis of revenue from various segments:
Source Types
Methodology Types
Application Types
Major Geographies
1 Research Methodology
2 Research Objectives
3 Research Process
4 Report Coverage
4.1 Market Definition
4.2 Base Year
4.3 Scope of Study
4.3.1 Market Segmentation by Source Type
4.3.2 Market Segmentation by Methodology
4.3.3 Market Segmentation by Application
4.3.4 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Currency Conversion rate
5.2 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Overview Of Nervous System and Neurophysiology
7.2 Introduction to IONM
7.3 Evolution of IONM
7.4 Standard STAGES in IONM
7.4.1 Pre-operative Preparation
7.4.2 Baseline IONM Recording
7.4.3 Perioperative IONM Recording
7.4.4 IONM Documentation
7.4.5 Interpretive Report Preparation
7.5 Key Advantages of IONM
8 Reimbursement Scenario
8.1 Background
8.2 Reimbursement Scenario in North America
8.2.1 Reimbursement Scenario in US
8.2.2 Overview of IONM Reimbursement
8.2.3 Outline of Coding Considerations-
8.3 Reimbursement Scenario in Europe
8.3.1 Reimbursement Scenario in UK
8.3.2 Reimbursement Scenario in France
8.3.3 Reimbursement Scenario in Germany
8.3.4 Reimbursement Scenario in Italy
8.3.5 Reimbursement Scenario in Spain
8.4 Reimbursement Scenario in Latin America
8.4.1 Reimbursement Scenario in Mexico
8.5 Reimbursement Scenario in APAC
8.5.1 Reimbursement Scenario in Japan
8.5.2 Reimbursement Scenario in Australia
9 Market Dynamics
9.1 Market Growth Enablers
9.1.1 Increase in Volume of Surgical Procedures
9.1.2 Increased Utility of IONM in Varied Surgeries
9.1.3 Technological Advancements
9.1.4 Increased Use of Out-sourced IONM by Small and Rural Healthcare Centers
9.1.5 YOY Impact of Market Enablers
9.2 Market Growth Restraint
9.2.1 Low Awareness and Adoption of IONM in Emerging Countries
9.2.2 Limited Skilled Healthcare Professionals
9.2.3 High Cost of IONM Utilized Surgeries
9.2.4 Associated Complications of IONM
9.2.5 YOY Impact of Market Restraints
9.3 Market Opportunities & Trends
9.3.1 High Demand for Tele-Neuromonitoring
9.3.2 Advent of Portable and Multi-modality IONM Devices
9.3.3 Increase in Strategic Consolidation
9.3.4 Integration of MI Surgeries with IONM
9.3.5 YOY Impact of Trends and Opportunities
10 Global IONM Market
10.1 market Overview
10.2 Market Size & Forecast
10.3 Porter’s Five Forces Analysis
10.3.1 Threat of New Entrants
10.3.2 Bargaining Power of Suppliers
10.3.3 Bargaining Power of Buyers
10.3.4 Threat of Substitutes
10.3.5 Competitive Rivalry
11 IONM Market- By Source Type
11.1 Market Overview
11.2 In-Sourced IONM Market
11.3 Outsourced IONM Market
12 IONM Market- By Modality
12.1 Segment Overview
12.2 Evoked Potential (EP) Market
12.2.1 Market Size & Forecast
12.3 Detailed Description of EP Types
12.3.1 Somatosensory evoked potentials (SSEP)
12.3.2 Motor Evoked Potentials (MEP)
12.3.3 Visual Evoked Potential (VEP)
12.3.4 Brainstem Auditory Evoked Potential (BAEP)
12.4 Electromyography (EMG)
12.4.1 Market Size & Forecast
12.4.2 Free-running EMG
12.4.3 Stimulated EMG
12.5 Electroencephalogram (EEG) Market
13 Global IONM Market – By Application
13.1 Segment Overview
13.2 NEURAL Surgeries
13.2.1 Market Size & Forecast
13.3 Orthopedic Surgeries
13.3.1 Market Size & Forecast
13.4 ENT Surgeries
13.4.1 Market Size & Forecast
13.5 Cardiovasular Surgeries
13.5.1 Market Size & Forecast
14 IONM Market - By Geography
14.1 Market Overview
15 North America: IONM Market
15.1 Market Overview
15.2 Market Size & Forecast
15.3 Leading Trends, Enablers, and Restraints
15.4 Key Countries
15.4.1 US: Market Size & Forecast
15.4.2 Canada: Market Size & Forecast
16 Europe: IONM Market
16.1 Market Overview
16.2 Market Size & Forecast
16.3 Leading Trends, Enablers, and Restraints
16.4 Key Countries
16.4.1 Germany: Market Size & Forecast
16.4.2 UK: Market Size & Forecast
16.4.3 France, Italy, and Spain: Market Size and Forecast
17 APAC: IONM Market
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Leading Trends, Enablers, and Restraints
17.4 Key Countries
17.4.1 Japan: Market Size & Forecast
17.4.2 Australia: Market Size & Forecast
17.4.3 China and India: Market Size & Forecast
18 Latin America: IONM Market
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Major Trends, Enablers, and Restraints
18.4 Key Countries
18.4.1 Mexico: Market Size & Forecast
18.4.2 Brazil: Market Size & Forecast
19 Middle East & Africa: IONM Market
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Major Trends, Enablers, and Restraints
20 Competitive Landscape
20.1 Competition overview
21 Key Company Profiles
21.1 SpecialtyCare
21.1.1 Key Highlights
21.1.2 Strength Assessment
21.1.3 Strategy Assessment
21.1.4 Opportunity Assessment
21.2 Natus Medical Incorporated
21.2.1 Key Highlights
21.2.2 Strength Assessment
21.2.3 Strategy Assessment
21.2.4 Opportunity Assessment
21.3 NuVasive Inc
21.3.1 Key Highlights
21.3.2 Strength Assessment
21.3.3 Strategy Assessment
21.3.4 Opportunity Assessment
21.4 Medtronic plc
21.4.1 Key Highlights
21.4.2 Strength Assessment
21.4.3 Strategy Assessment
21.4.4 Opportunity Assessment
21.5 inomed Medizintechnik GmbH
21.5.1 Key Highlights
21.5.2 Strength Assessment
21.5.3 Opportunity Assessment
21.5.4 Strategy Assessment
22 Other Prominent Companies
22.1 Accurate Monitoring
22.1.1 Strength Assessment
22.1.2 Strategy Assessment
22.1.3 Opportunity Assessment
22.2 Cadwell Industries INC.
22.2.1 Strength Assessment
22.2.2 Strategy Assessment
22.2.3 Opportunity Assessment
22.3 Computational Diagnostics INC.
22.3.1 Strength Assessment
22.3.2 Strategy Assessment
22.3.3 Opportunity Assessment
22.4 Bromedicon Neuromonitoring LLC
22.4.1 Strength Assessment
22.4.2 Strategy Assessment
22.4.3 Opportunity Assessment
22.5 Clinical Neurodiagnostics LLC
22.5.1 Strength Assessment
22.5.2 Strategy Assessment
22.5.3 Opportunity Assessment
22.6 CNS Neuromonitoring
22.6.1 Strength Assessment
22.6.2 Strategy Assessment
22.6.3 Opportunity Assessment
22.7 Dr. Langer Medical
22.7.1 Strength Assessment
22.7.2 Strategy Assessment
22.7.3 Opportunity Assessment
22.8 IntraNerve LLC
22.8.1 Strength Assessment
22.8.2 Strategy Assessment
22.8.3 Opportunity Assessment
22.9 Medsurant Health LLC
22.9.1 Strength Assessment
22.9.2 Strategy Assessment
22.9.3 Opportunity Assessment
22.1 Neuro Alert
22.10.1 Strength Assessment
22.10.2 Strategy Assessment
22.10.3 Opportunity Assessment
22.11 Neurophysiology Services Asia
22.11.1 Strength Assessment
22.11.2 Strategy Assessment
22.11.3 Opportunity Assessment
22.12 Nihon Kohden CORP.
22.12.1 Strength Assessment
22.12.2 Strategy Assessment
22.12.3 Opportunity Assessment
23 Report Summary
23.1 Key Takeaways
23.2 Qualitative Summary of Global IONM Market
23.3 Quantitative Summary of Global IONM Market
24 Appendix
24.1 List of Abbreviations
List of Exhibits
Exhibit 1 Segmentation of Global IONM Market
Exhibit 2 Market Size Calculation Approach 2016
Exhibit 3 Schematic Representation of Neurotransmission
Exhibit 4 Mechanism of IONM
Exhibit 5 Common IONM Modalities
Exhibit 6 Evolution of IONM
Exhibit 7 Standard Steps Followed in IONM
Exhibit 8 Key Advantages of IONM
Exhibit 9 Increase in Volume of Select Surgical Procedures in US (in thousands)
Exhibit 10 Increase in Number of Hospitals Utilizing IONM in US 2008 and 2012
Exhibit 11 Common Specialist Areas Utilizing IONM Techniques
Exhibit 12 Snapshot of Out-sourced IONM’s Benefits Over In-sourced IONM
Exhibit 13 Global Outsourced IONM Market ($million)
Exhibit 14 Additional Costs of IONM Utilized MIS-TLIF Surgery
Exhibit 15 Demand for Remote IONM in US
Exhibit 16 List of Key Portable and Multi-Modal IONM Devices
Exhibit 17 Overview of Global Disease Burden and Need For IONM
Exhibit 18 Global IONM Market 2016–2022 ($ million)
Exhibit 19 Five Forces Analysis 2016
Exhibit 20 Global IONM Market by Source Type
Exhibit 21 Percentage Share of In-sourced and Out-sourced IONM 2016 and 2022
Exhibit 22 Global IONM Market by Source Type ($ million)
Exhibit 23 Comparison of Growth Rates for Out-sourced and In-sourced IONM Segments
Exhibit 24 Key Beneficial Aspects and Drawbacks of In-sourced IONM
Exhibit 25 Global In-sourced IONM Market Size and Forecast ($ million)
Exhibit 26 End-users of Out-Sourced IONM Service Providers
Exhibit 27 Key Benefits of Outsourced IONM Services
Exhibit 28 Global Out-sourced IONM Market Size and Forecast ($ million)
Exhibit 29 Global IONM Market by Modality
Exhibit 30 Percentage Share of EP, EMG, and EEG
Exhibit 31 Global IONM Market Lucrativeness by Modality
Exhibit 32 Global IONM Market by Modality ($ million)
Exhibit 33 Comparison of Growth Rates for EP, EMG, and EEG
Exhibit 34 Types of Evoked Potentials Used as IONM Modalities
Exhibit 35 Global EP Market Size and Forecast ($ million)
Exhibit 36 Common MEP Indicated Surgeries
Exhibit 37 Common VEP Indicated Surgeries
Exhibit 38 Common BAEP Indicated Surgeries
Exhibit 39 Snapshot of Basic EMG Techniques
Exhibit 40 Key EMG Indicated Surgeries
Exhibit 41 Global Electromyography Market Size and Forecast ($ million)
Exhibit 42 Key EEG Indicated Surgeries
Exhibit 43 Global EEG Market Size and Forecast ($ million)
Exhibit 44 Global IONM Market by Application
Exhibit 45 Percentage Share of Surgical Specialties 2016 and 2022
Exhibit 46 Global IONM Market Lucrativeness by Application 2022
Exhibit 47 Incidence of Brain and Nervous System Tumors (in ‘000)
Exhibit 48 Increase in IONM Utilization Rate for Simple Fusions and Laminectomies in US
Exhibit 49 Global IONM Market Size for Neural Surgeries ($ million)
Exhibit 50 Hip replacements Surgical Volume in Select OECD Countries (in ‘000)
Exhibit 51 Global IONM Market Size for Orthopedic Surgeries ($ million)
Exhibit 52 Incidence of Thyroid Cancer (in ‘000)
Exhibit 53 Global IONM Market Size for ENT Surgeries ($ million)
Exhibit 54 Decrease in CABG Surgical Volume in Select OECD countries
Exhibit 55 Global IONM Market Size for Cardiovascular Surgeries ($ million)
Exhibit 56 Global IONM Market by Geography
Exhibit 57 IONM Market by Geography ($ million)
Exhibit 58 Market Revenue Growth Rates Comparison by Geography
Exhibit 59 Global IONM Market Lucrativeness by Geography 2022
Exhibit 60 IONM Market in North America by Country 2016
Exhibit 61 IONM Market in North America 2016–2022 ($ million)
Exhibit 62 Key IONM Market Dynamics in North America
Exhibit 63 Increase in Select Surgical Procedures in US (in '000's)
Exhibit 64 IONM Market in the US 2016–2022 ($ million)
Exhibit 65 Increase in Volume of Select Surgeries in Canada 2006–2015
Exhibit 66 IONM Market in Canada 2016–2022 ($ million)
Exhibit 67 IONM Market in Europe by Country 2016
Exhibit 68 IONM Market in Europe ($ million)
Exhibit 69 Key IONM Market Dynamics in Europe
Exhibit 70 Increase in Volume of Select Surgeries in Germany 2006–2015
Exhibit 71 IONM Market in Germany 2016–2022 ($ million)
Exhibit 72 Increase in Volume of Select Surgeries in UK
Exhibit 73 IONM Market in UK ($ million)
Exhibit 74 Increase in Volume of Total Knee Replacement in France, Italy, and Spain 2006–2015
Exhibit 75 IONM Market in France ($ million)
Exhibit 76 IONM Market in Italy ($ million)
Exhibit 77 IONM Market in Spain ($ million)
Exhibit 78 IONM Market in APAC ($ million)
Exhibit 79 Key IONM Market Dynamics in APAC
Exhibit 80 IONM Market in Japan 2016–2022 ($ million)
Exhibit 81 IONM Market in Australia ($ million)
Exhibit 82 IONM Market in China ($ million)
Exhibit 83 IONM Market in India ($ million)
Exhibit 84 IONM Market in Latin America ($ million)
Exhibit 85 Key IONM Market Dynamics in Latin America
Exhibit 86 Increase in Common Surgical Procedures in Mexico
Exhibit 87 IONM Market in Mexico ($ million)
Exhibit 88 IONM Market in Brazil ($ million)
Exhibit 89 IONM Market in MEA 2016–2022 ($ million)
Exhibit 90 Key IONM Market Dynamics in Latin America
Exhibit 91 Snapshot of IONM Competitive Scenario
List of Tables
Table 1 Key Geographies Definition
Table 2 Key Caveats
Table 3 Currency Conversion 2013−2016
Table 4 Federally Funded Key Health Insurance Programs in US
Table 5 IONM Related Primary CPT Codes (2017)
Table 6 IONM Add-on Reimbursement Codes Description, 2017
Table 7 IONM Add-on Reimbursement Codes, Key Considerations
Table 8 Description of Advanced Features of Select IONM Equipment
Table 9 YOY Impact of Market Enablers 2016–2022
Table 10 Limitations of Select IONM Modalities
Table 11 YOY Impact of Market Restraints 2016–2022
Table 12 Key Mergers and Acquisitions in Global IONM Market
Table 13 YOY Impact of Trends and Opportunities 2016–2022
Table 14 Global IONM Market by Source-Type, 2016 – 2022 ($ million)
Table 15 Global IONM Market by Modality, 2016 – 2022 ($ million)
Table 16 Key Surgeries Monitored through SSEP
Table 17 Global IONM Market by Application, 2016 – 2022 ($ million)
Table 18 Common IONM Procedures Recommended for Specific Neural Procedures
Table 19 Common IONM Procedures Recommended for Specific Orthopedic Procedures
Table 20 Common IONM Procedures Recommended for Specific ENT Procedures
Table 21 Global IONM Market by Geography, 2016 – 2022 ($ million)
Table 22 Natus Medical: IONM Product Portfolio 2017
Table 23 Medtronic IONM Product Portfolio
Table 24 inomed's IONM Product Portfolio 2017
Table 25 Qualitative Summary of Global IONM Market
Table 26 Quantitative Summary of Global IONM Market by Geography ($ million)
Table 27 Quantitative Summary of Global IONM Market by Geography (Revenue %)
Table 28 Quantitative Summary of Global IONM Market by Source Type ($ million)
Table 29 Quantitative Summary of Global IONM Market by Modality ($ million)
Table 30 Quantitative Summary of Global IONM Market by Application ($ million)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
